$33.32
+0.460 (+1.40%)
At Close: Jun 03, 2026
Harrow Health: Mostly Good, Some Bad
12:20pm, Monday, 12'th Jun 2023
Harrow Healthcare is well-positioned to grow in the US Ophthalmology market, with a branded pharma sales strategy that could boost growth and margins. The company's medium-term earnings outlook is str
Analysts Initiate Coverage: 5 Stocks for Higher Returns
12:55pm, Monday, 15'th May 2023
Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like MicroStrategy (MSTR), SPX Technologies (SPXC), Cvent (CVT), Harrow Health (HROW) and Banco (BM
Why Shares of Harrow Health Are Slumping Friday
01:48pm, Friday, 12'th May 2023
Harrow had a $6.6 million loss in the first quarter. It just launched its latest therapy, the ocular anesthesia Iheeza.
Harrow Health, Inc. (HROW) Q1 2023 Earnings Call Transcript
09:43pm, Thursday, 11'th May 2023
Harrow Health, Inc. (NASDAQ:HROW ) Q1 2023 Earnings Conference Call May 11, 2023 4:45 PM ET Company Participants Jamie Webb - Director, Communications and IR Mark Baum - Chief Executive Officer Andrew
Harrow Health (HROW) Reports Q1 Loss, Tops Revenue Estimates
07:02pm, Thursday, 11'th May 2023
Harrow Health (HROW) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to earnings of $0.03 per share a year ago.
Harrow Health (HROW) to Report Q1 Earnings: What's in the Offing?
01:43pm, Monday, 08'th May 2023
Harrow Health's (HROW) first-quarter top line is likely to have been driven by its recent product launches.
5 Stocks With Recent Price Strength That Still Have Upside
08:22am, Wednesday, 03'rd May 2023
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are META, CMG, ACLX, HROW and PRG.
Here's Why Momentum in Harrow (HROW) Should Keep going
09:55am, Monday, 01'st May 2023
Harrow (HROW) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our sho
Bull Of The Day: Harrow Health (HROW)
08:24am, Monday, 24'th Apr 2023
This "roll up" play is expected to post some good growth this year as well as next.
5 Small Hidden Gems to Pick From a Rangebound Wall Street
09:56am, Thursday, 20'th Apr 2023
We have narrowed our search to five stocks that have provided more than 50% returns year to date with more upside left. These are: CRD.A, REPX, UVE, ASUR and HROW.
5 Stocks With Recent Price Strength to Maximize Your Gains
07:38am, Tuesday, 18'th Apr 2023
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are TGLS, CRD.B, REPX, HROW and LNTH.
5 Stocks With Recent Price Strength Amid March Rally
08:22am, Monday, 03'rd Apr 2023
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are BLPH, CRD.B, REPX, HROW and LNTH.
Harrow (HROW) is on the Move, Here's Why the Trend Could be Sustainable
09:59am, Wednesday, 29'th Mar 2023
Harrow (HROW) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Harrow Health, Inc. (HROW) Q4 2022 Earnings Call Transcript
08:58pm, Thursday, 23'rd Mar 2023
Harrow Health, Inc. (NASDAQ:HROW ) Q4 2022 Earnings Conference Call March 23, 2023 4:45 PM ET Company Participants Jamie Webb - Director, Communications and IR Mark Baum - Chief Executive Officer Andr
Buy Harrow Health: Correcting A Shortsighted View
10:42am, Thursday, 23'rd Feb 2023
Harrow entered an opaque market filled with middle men and dissatisfied ophthalmologists. Harrow understands their customers, solves their pain points, and has earned their trust. This is a deep moat.
Sign In
Buy HROW